shaping the future of rare disease care in canada: new report outlines key considerations for fund allocation
a new report created by takeda pharmaceutical company highlights six key areas of unmet needs, offering an outline of how policymakers can go about making rare disease drug access and care better in canada.
angelica bottaro,
aug 22 2024